
Sobi is an international biopharmaceutical company, dedicated to providing access to innovative treatments that transform life for people with rare diseases in the areas of haematology, immunology and specialty care. With our head office in Stockholm, Sweden, Sobi also has premises in Basel, Switzerland. You can find more information about Sobi at www.sobi.com
The Head of Global Medical Publications is tasked with leading and mentoring a team of publications managers, ensuring their professional development and effective project execution. The Head is responsible for the coordination and standardisation of operational activities of systems, processes, policies, and frameworks that support the planning, execution, and governance of scientific and medical publications activities across the Therapeutic Areas. The Head collaborates with Global Medical Affairs and Clinical Development (MACD), regional partners and other relevant departments to execute and integrate publications operational needs and activities, and ensures adequate resourcing aligned to identified priorities. The Head remains updated on relevant regulations and industry standards related to publications, ensuring compliance in all activities. The Head is a member of the Medical Excellence and Operations Leadership Team, providing input to share best practices, drive a supportive and collaborative culture and enable achievement of organisational goals.
Key Responsibilities
Personal Attributes

Sobi is a global biopharma company unlocking the potential of breakthrough innovations, transforming everyday life for people living with rare diseases.
We are dedicated to capturing the scientific opportunities of our time. With our early roots in Sweden, we started as pioneers in haemophilia. Today we are an innovative leader within rare diseases with a global reach. Together we are bringing brilliant ideas to life.
Sobi has approximately 1,900 employees across Europe, North America, the Middle East, Asia and Australia. In 2024, revenue amounted to SEK 26 billion. Sobi’s share (STO:SOBI) is listed on Nasdaq Stockholm. More about Sobi at sobi.com and LinkedIn.